APELLIS PHARMACEUTICALS INC

CUSIP: 03753UAB2 Class: NOTE 3.500% 9/1

PALISADE CAPITAL MANAGEMENT, LP's Holding History (CIK: 0001009006)

Note: Option positions (PUT/CALL) are excluded.

Q4 2023
Shares 1,017,000 Value ($000) $1,670 Avg Close — Range —
Q3 2023
Shares 1,017,000 Value ($000) $1,285 Avg Close — Range —
Q2 2023
Shares 1,267,000 Value ($000) $3,044 Avg Close — Range —
Q1 2023
Shares 1,492,000 Value ($000) $2,777 Avg Close — Range —
Q4 2022
Shares 1,617,000 Value ($000) $2,488 Avg Close — Range —
Q3 2022
Shares 1,167,000 Value ($000) $2,273 Avg Close — Range —
Q2 2022
Shares 1,017,000 Value ($000) $1,517 Avg Close — Range —
Q1 2022
Shares 1,017,000 Value ($000) $1,607 Avg Close — Range —
Q4 2021
Shares 1,017,000 Value ($000) $1,537 Avg Close — Range —
Q2 2021
Shares 3,306,000 Value ($000) $6,173 Avg Close — Range —
Q1 2021
Shares 2,370,000 Value ($000) $3,344 Avg Close — Range —
Q4 2020
Shares 2,370,000 Value ($000) $3,983 Avg Close — Range —
Q3 2020
Shares 2,370,000 Value ($000) $2,561 Avg Close — Range —